ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,811.09
-1.60%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.00%
US Dollar vs Yen
158.424
0.18%
Brent Oil
83.005
-1.58%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) ニュース

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VNDA
日付受信時刻ニュースソース見出しコード企業名
2019/12/1307 : 15PR Newswire (US)Mihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Respon...NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/11/1906 : 01PR Newswire (US)Vanda Pharmaceuticals Announces Participation at November 2019 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/11/0721 : 04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/11/0706 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/11/0706 : 01PR Newswire (US)Vanda Pharmaceuticals Reports Third Quarter 2019 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/10/3105 : 30PR Newswire (US)Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/10/2905 : 56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/10/2905 : 30PR Newswire (US)Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of DirectorsNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/10/2405 : 01PR Newswire (US)Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle DogsNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/10/1705 : 01PR Newswire (US)Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enfo...NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/09/1206 : 20PR Newswire (US)Vanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administ...NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/2905 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/2205 : 53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/2205 : 49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/2205 : 46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/2120 : 00PR Newswire (US)Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketin...NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/1920 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/1920 : 00PR Newswire (US)Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag DisorderNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/1605 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/0120 : 05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/0105 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/08/0105 : 01PR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2019 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/07/2305 : 01PR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/07/2221 : 35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/07/2220 : 00PR Newswire (US)Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag DisorderNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/07/1706 : 25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/07/1705 : 15PR Newswire (US)Tradipitant Effective in Preventing Motion SicknessNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/06/2505 : 59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2019/06/1822 : 50PR Newswire (US)Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2019/06/1806 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VNDA

最近閲覧した銘柄

CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NYSE
NKE
Nike
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有